Jane Moate – NeRRe Therapeutics

European Respiratory Society International Congress, Madrid 29 September 2019 Dr Steve Pawsey, CMO at NeRRe Therapeutics presents a poster at the European Respiratory Society, Madrid 29 September [...]

By Jane Moate

In News

Posted 27th August 2019

NeRRe Therapeutics Announces Publication of Positive Results in a Phase 2 Pilot Study of Orvepitant in Chronic Refractory Cough

By Jane Moate

In News

Posted 7th June 2019

NeRRe Therapeutics announces positive findings from Phase 2b study with orvepitant in chronic cough

By Jane Moate

In News

Posted 4th January 2019

Dr Mary Kerr CEO NeRRe Therapeutics presents at the Biotech Showcase, San Francisco

8th January 2019: NeRRe Therapeutics CEO, Dr Mary Kerr, presents at the Biotech Showcase, 10:30 Franciscan – D (Ballroom Level), Hilton San Francisco, San Francisco, CA 94102, USA

By Jane Moate

In Company News

Posted 3rd December 2018

Dr Mike Trower CSO KaNDy Therapeutics will be giving an invited presentation entitled: ‘ Switching off the heat: A novel, rapidly acting and effective non-hormonal approach to treating hot flashes and other symptoms of the menopause with neurokinin-1,3 receptor antagonism’

Please fill out the form to get in touch with us.